We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$16.6B
AUM Growth
+$973M
Cap. Flow
-$466M
Cap. Flow %
-2.8%
Top 10 Hldgs %
30.85%
Holding
337
New
11
Increased
98
Reduced
190
Closed
11

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$43.9M
2
DELL icon
Dell
DELL
+$36.8M
3
CME icon
CME Group
CME
+$29.7M
4
AFG icon
American Financial Group
AFG
+$18.4M
5
WMB icon
Williams Companies
WMB
+$16.6M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$49.2M
2
AVGO icon
Broadcom
AVGO
+$43.2M
3
UPS icon
United Parcel Service
UPS
+$26.7M
4
PLD icon
Prologis
PLD
+$26.4M
5
ABT icon
Abbott
ABT
+$26M

Sector Composition

Rank Sector Weight
1 Technology 22.48%
2 Healthcare 14.22%
3 Financials 13.06%
4 Industrials 12.03%
5 Consumer Staples 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
G icon
176
Genpact
G
$5.76B
$3.82M 0.02%
110,119
-447,710
-80% -$15.4M
CPK icon
177
Chesapeake Utilities
CPK
$3.21B
$3.77M 0.02%
35,685
+2,439
+7% +$232K
OLED icon
178
Universal Display
OLED
$4.19B
$3.55M 0.02%
18,544
+256
+1% +$42.3K
LFUS icon
179
Littelfuse
LFUS
$11.6B
$3.42M 0.02%
12,777
+1,891
+17% +$453K
LIN icon
180
Linde
LIN
$226B
$3.29M 0.02%
8,016
-163
-2% -$64.3K
DUK icon
181
Duke Energy
DUK
$97.3B
$3.25M 0.02%
33,527
+825
+3% +$75K
ORCL icon
182
Oracle
ORCL
$423B
$3.24M 0.02%
30,725
-819
-3% -$89.4K
ET icon
183
Energy Transfer Partners
ET
$69.3B
$3.15M 0.02%
228,569
+769
+0.3% +$10.5K
TPL icon
184
Texas Pacific Land
TPL
$23.5B
$3.14M 0.02%
18,000
IPG
185
DELISTED
Interpublic Group of Companies
IPG
$2.98M 0.02%
91,161
+1,369
+2% +$41.2K
VLO icon
186
Valero Energy
VLO
$85.9B
$2.87M 0.02%
22,046
+338
+2% +$43K
DCI icon
187
Donaldson
DCI
$11.4B
$2.83M 0.02%
43,286
-25
-0.1% -$1.52K
ATR icon
188
AptarGroup
ATR
$8.61B
$2.53M 0.02%
20,491
-300
-1% -$37.7K
META icon
189
Meta Platforms (Facebook)
META
$1.51T
$2.42M 0.01%
6,838
+215
+3% +$70K
AMT icon
190
American Tower
AMT
$80.4B
$2.38M 0.01%
11,023
-10,486
-49% -$1.98M
BWXT icon
191
BWX Technologies
BWXT
$15.6B
$2.38M 0.01%
30,959
+5,039
+19% +$387K
EFA icon
192
iShares MSCI EAFE ETF
EFA
$80.2B
$2.37M 0.01%
31,512
-75
-0.2% -$5.3K
CLX icon
193
Clorox
CLX
$12.7B
$2.37M 0.01%
16,624
-278
-2% -$37.1K
PFE icon
194
Pfizer
PFE
$153B
$2.36M 0.01%
81,991
-18,225
-18% -$551K
UTZ icon
195
Utz Brands
UTZ
$1.25B
$2.33M 0.01%
143,600
-2,253
-2% -$29.7K
A icon
196
Agilent Technologies
A
$41.2B
$2.32M 0.01%
16,705
-6,185
-27% -$736K
DHI icon
197
D.R. Horton
DHI
$42.3B
$2.31M 0.01%
15,185
-110
-0.7% -$13.5K
KR icon
198
Kroger
KR
$34.8B
$2.3M 0.01%
50,413
-126
-0.2% -$5.6K
SHEL icon
199
Shell
SHEL
$245B
$2.29M 0.01%
34,850
-1,000
-3% -$65.6K
NSC icon
200
Norfolk Southern
NSC
$75.1B
$2.27M 0.01%
9,583
+123
+1% +$25.8K

Similar funds

Bahl & Gaynor's Q4 2023 Portfolio in Review

As of Q4 2023, Bahl & Gaynor held 337 positions worth $16.6B, up 6.2% from $15.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2023 filing shows 11 new, 98 increased, 190 reduced and 11 closed positions. Its largest new stake was Dell: 520,900 shares worth $39.8M. The largest sale was Medtronic, an estimated $49.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2023 buy was Dell: 520,900 shares worth $39.8M.
  • Bahl & Gaynor added most to Amgen in Q4 2023, an estimated $43.9M increase.
  • Bahl & Gaynor's biggest Q4 2023 reduction was Medtronic, cutting an estimated $49.2M.
  • Bahl & Gaynor fully exited SBA Communications in Q4 2023, selling an estimated $375K.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $16.6B portfolio in Q4 2023.
  • Bahl & Gaynor opened 11 new positions and closed 11 in Q4 2023.
  • Bahl & Gaynor's portfolio value rose 6.2% quarter-over-quarter to $16.6B.

Based on Bahl & Gaynor's 13F filing for Q4 2023, filed 2 Feb 2024.